Ovarian cancer gene hunt: 300 patients to shape future therapies
NCT ID NCT06127446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to collect and analyze genetic information from 300 Taiwanese women with ovarian cancer. Researchers will look at tumor samples and medical records to find gene changes linked to treatment response and survival. The goal is to build a database that helps develop personalized treatments and improve outcomes for ovarian cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cathay General Hospital
RECRUITINGTaipei, Taiwan
-
Chang Gung Medical Foundation
RECRUITINGKaohsiung City, Taiwan
-
China Medical University Hospital
RECRUITINGTaichung, Taiwan
-
Kaohsiung Veterans General Hospital
RECRUITINGKaohsiung City, Taiwan
-
Mackay Memorial Hospital
RECRUITINGTaipei, Taiwan
-
National Cheng Kung University Hospital
RECRUITINGTainan, Taiwan
-
National Taiwan University Hospital
RECRUITINGTaipei, Taiwan
-
Taichung Veterans General Hospital
RECRUITINGTaichung, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?
- Can Lab-Grown tumors unlock the secrets of ovarian cancer resistance?
- Can a smart drug home in on Hard-to-Treat cancers?